Completeness of salpingectomy intended for ovarian cancer risk reduction
Gynecologic Oncology Sep 20, 2019
Wong JWH, et al. - Researchers evaluated women without a history of ovarian cancer who were undergoing salpingoophorectomy at a single institution in Honolulu, Hawaii to determine the completeness of salpingectomy intended for ovarian cancer risk reduction in these women. This is the largest blinded study on this topic as well as is the only study to compare learner vs attending outcomes in this setting. The women underwent salpingectomy prior to oophorectomy. The ovaries were then examined by a blinded pathologist for the presence of residual salpingeal tissue. Among 107 ovaries examined, 5.6% (n = 6/107) of ovaries showed the presence of residual salpingeal tissue and 94.4% (n = 101/107) of ovaries showed no salpingeal tissue. This suggests complete removal of salpingeal tissue in over 94% of salpingectomies. No difference among surgeon level and surgery type, was observed for the ovaries with residual salpingeal tissue, however, the study was not powered to detect this. Findings thereby promote the continued clinical practice of prophylactic salpingectomy for ovarian cancer risk mitigation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries